Key Events This Week
5 Jan: Stock opens week at Rs.150.25 amid mixed technical signals
6 Jan: Intensified bearish momentum drives price down to Rs.144.30 (-3.96%)
7 Jan: Intraday high of Rs.154.40 with 7.02% surge, signalling short-term rebound
8 Jan: Strong intraday rally to Rs.166.50 (+7.85%), outpacing sector and Sensex
9 Jan: Week closes at Rs.153.10, slightly down from previous day (-0.94%)

Camlin Fine Sciences Ltd Hits Intraday High with 7.85% Surge on 8 Jan 2026
2026-01-08 09:31:22Camlin Fine Sciences Ltd recorded a robust intraday performance on 8 Jan 2026, surging to an intraday high of Rs 166.5, marking a 10.23% rise from its previous close. The specialty chemicals company outperformed its sector and broader market indices, driven by strong trading momentum and notable volatility.
Read full news article
Camlin Fine Sciences Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-01-08 08:03:41Camlin Fine Sciences Ltd, a key player in the specialty chemicals sector, has experienced a nuanced shift in its technical momentum, with several indicators signalling a transition from bearish to mildly bearish trends. Despite a notable 5.52% gain in the latest trading session, the company’s overall technical profile remains cautious, reflecting mixed signals from MACD, RSI, moving averages, and other momentum indicators.
Read full news article
Camlin Fine Sciences Ltd Hits Intraday High with 7.02% Surge on 7 Jan 2026
2026-01-07 10:11:04Camlin Fine Sciences Ltd recorded a robust intraday performance on 7 January 2026, surging to a day’s high of Rs 154.4, marking a 7.86% increase from its previous close. This sharp uptick outpaced the broader market and sector indices, signalling a notable reversal after two days of decline.
Read full news article
Camlin Fine Sciences Ltd Faces Intensified Bearish Momentum Amid Technical Deterioration
2026-01-06 08:06:04Camlin Fine Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a Strong Sell rating reflects deteriorating price action and weakening market sentiment, underscored by a 3.96% decline in the latest trading session and a current price of ₹144.30. This article analyses the technical parameters shaping the stock’s outlook and places its performance in the context of broader market movements.
Read full news article
Camlin Fine Sciences Ltd Sees Mixed Technical Signals Amid Mild Bearish Momentum
2026-01-05 08:01:33Camlin Fine Sciences Ltd, a specialty chemicals company, has experienced a subtle shift in price momentum, reflected in a complex blend of technical indicators that suggest a cautious outlook. Despite a modest day gain of 2.39%, the stock’s technical parameters reveal a transition from bearish to mildly bearish trends, prompting a reassessment of its near-term prospects.
Read full news article
Camlin Fine Sciences Ltd is Rated Strong Sell
2026-01-02 10:10:03Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 02 January 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Camlin Fine Sciences Technical Momentum Shifts Amid Mixed Market Signals
2025-12-26 08:01:12Camlin Fine Sciences, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price movement and indicator behaviour, underscoring the importance of a detailed technical analysis for investors navigating this stock’s trajectory.
Read full news article
Camlin Fine Sees Revision in Market Evaluation Amidst Weak Fundamentals
2025-12-22 10:10:18Camlin Fine, a small-cap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting challenges in its financial and technical outlook. Recent assessment changes highlight concerns over the company’s long-term profitability and investor participation, signalling a cautious stance from market analysts.
Read full news article





